Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Argatroban separation method

A technology for the separation of argatroban and its separation method, which is applied in the field of separation of the optical isomer compound argatroban, and can solve problems such as unsuitability for industrial production, low yield, and failure to reach a practical level.

Active Publication Date: 2007-04-25
TIANJIN WEIJIE TECH
View PDF4 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The physical and chemical properties of 21(R) and 21(S) are very close, and it is very difficult to completely separate them. It has been reported that preparative chromatographic separation after derivatization, column chromatography and protein A chromatographic separation [US 6440417, Journal of Pharmaceutical Sciences, Vo1. 82, No.6, 672 (1993)], the separation amount is small, the yield is low, and it has not yet reached the level of practical grade
[0014] When L-arginine is directly condensed with quinolinesulfonyl chloride, there are many reaction by-products, which are not easy to separate, and are not suitable for industrial production [Patent Bulletin Ping 1-35000]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Argatroban separation method
  • Argatroban separation method
  • Argatroban separation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1. Add 7 grams of Argatroban (R: S=65: 35) to 210 ml of 85% aqueous methanol solution, heat to reflux for 6 hours until transparent, cool to room temperature, and leave to stand for 5 hours to separate out white crystals, filter, 80 ° C Drying under high temperature, weight 5.6 grams, 21 (S) content 42.5% (HPLC method).

Embodiment 2

[0035] Example 2. 5 grams of Argatroban (R: S=30: 70) was added to 100 ml of 50% aqueous methanol solution, heated to reflux for 5 hours until transparent, cooled to room temperature, left to stand for 4 hours, and white crystals were precipitated, filtered and dried , weight 2.5 g, 21(S) content 85.0% (HPLC method).

Embodiment 3

[0036]Embodiment 3. 2 grams of Argatroban (R: S=23: 76), was added in 60ml of 20% aqueous methanol solution, heated to reflux for 3 hours to transparent, cooled to room temperature, left to stand for 3 hours, precipitated solid, filtered, dried to obtain 0.9 g of white crystals, 21(S) content 94.9% (HPLC method).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a separating method of optically-active pure isomer 21 (S)-Argatroban, which comprises the following steps: adopting 21(S) and 21(R) Argatroban as raw material; heating to reflux based on mixture of alcohol and water as solvent for 5-10h; cooling; stewing; filtering; obtaining white crystal product; drying; repeating 2-6 times; combining mother liquid; stripping solvent; detecting the content of 21 (S) through high-effect liquid-phase chromatography not less than 98%.

Description

technical field [0001] The invention relates to a method for separating optical isomer compound Argatroban (Argatroban), in particular to a method for separating pure 21(S)-argatroban. Background technique [0002] In 1978, S.Okamoto of Mitsubishi Chemical Company in Japan firstly reported the antithrombin activity of Argatroban (Argatroban) monohydrate [US 4 101 653]. During the following 20 years, many researchers conducted in-depth research on the biological activity of Argatroban and its value as medicine. In 1981, S.Okamoto compared heparin in animals [Okamoto, S.et al., Biochem.Biophys.Res.Commun.101, 440 (1981)]; T.Kumoto et al. Report [Kumada, T.et al., Thromb.Res.24, 285(1981)]; In 1984, R.Kumato conducted clinical hemodialysis evaluation [Kikumoto, R.et al., Biochemistry23, 85(1984)] ; In 1986, the author reported that Argatroban inhibited the thrombin activity in mammals, and could be used as a treatment and prevention agent for thrombosis and an inhibitor of pl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/12C07B57/00C07D211/00C07D215/00
Inventor 宋洪海
Owner TIANJIN WEIJIE TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com